Cutler Group’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Cutler Group’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-296	Closed	-$1K	–	7464
2017 Q1	$1K	Hold	296	–	–	﹤0.01%	6146
2016 Q4	$1K	Hold	296	–	–	﹤0.01%	6283
2016 Q3	$2K	Hold	296	–	–	﹤0.01%	5905
2016 Q2	$2K	Hold	296	–	–	﹤0.01%	5859
2016 Q1	$2K	Hold	296	–	–	﹤0.01%	5767
2015 Q4	$3K	Buy	+296	New	+$3.52K	﹤0.01%	5439

Other funds holding AVEO

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Cutler Group's AVEO Position: Q2 2017 in Review

Cutler Group sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q2 2017, closing a stake of 296 shares — an estimated $1K sold.

Cutler Group first reported a position in AVEO in Q4 2015 and held it in 6 quarters. The position peaked at $3K in Q4 2015. 49 funds tracked by Wall St. Rank hold AVEO as of Q2 2017.

Cutler Group reported no remaining AVEO Pharmaceuticals, Inc. position as of Q2 2017 after selling out during the quarter.
Cutler Group sold 296 AVEO Pharmaceuticals, Inc. shares in Q2 2017, an estimated $1K.
Cutler Group first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2015 and held it in 6 quarters.
Cutler Group's AVEO Pharmaceuticals, Inc. position peaked at $3K in Q4 2015.
49 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q2 2017.

Based on Cutler Group's 13F filing for Q2 2017, filed 11 Jul 2017.